Key facts
- Notable investors include S&G Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Phoenix Life Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Phoenix Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phoenix Life Science
Provider of life science research services and biotechnological research, intended for advancing molecular diagnostics and genetic analysis for clinical and pharmaceutical applications. The company offers gene sequencing, molecular diagnostic kits, cell culture reagents, and laboratory testing services, thereby enabling them to accelerate clinical research, improve diagnostic accuracy, and enhance therapeutic innovation.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Phoenix Life Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phoenix Life Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phoenix Life Science in its N-PORT filings yet. We sweep new filings monthly.